You got me there …. I trusted that Lake’s Executive Chairman was presenting complete, correct and consistent information to investors.
Shame on me hey!
DYOR
- Forums
- ASX - By Stock
- LKE
- Ann: LKE Bell Potter Unearthed Conference 070223
Ann: LKE Bell Potter Unearthed Conference 070223, page-44
-
-
Share
Exactly, what is your point? No one is saying reinjection is impossible. The issue here is Steve+Stu have been glossing over the details for years. Its now crunch time.
50+GL brine pa annum to be processed, the majority of that reinjected. What residual HCL and CL ions will be present in the brine? What treatment of the brine will be required before reinjection ? So far the company has provided ZERO information on reinjection, partly because they have done ZERO testing.
Wouldn't you agree that the information provided by the company up until now for wells+ reinjection is not satisfactory? Given the Executive Chairman stated that construction would start Q4 2022.
ps, still no guidance from you regarding your predictions for a realistic timeline. Its ok if you keep avoiding the question, ill keep asking it. No rush
- There are more pages in this discussion • 217 more messages in this thread...
Featured News
Add LKE (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
-0.002(3.75%) |
Mkt cap ! $64.23M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 3.8¢ | $216.5K | 5.522M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
48 | 4739514 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 39211 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
48 | 4716199 | 0.038 |
28 | 2726156 | 0.037 |
24 | 1810530 | 0.036 |
32 | 3977186 | 0.035 |
5 | 643851 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 39638 | 10 |
0.040 | 676615 | 12 |
0.041 | 701377 | 8 |
0.042 | 718188 | 9 |
0.043 | 549433 | 5 |
Last trade - 15.49pm 15/07/2024 (20 minute delay) ? |
Featured News
LKE (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online